B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) Behaves as an Acute Phase Reactant in Acute Pancreatitis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Pongratz, Georg ^a   Hochrinner, Hannah ^a   Straub, Rainer H ^a   Lang, Stefanie ^a   Brünnler, Tanja ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Saint John of God Hospital Regensburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APRIL PROTEIN; B CELL ACTIVATING FACTOR; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; APACHE; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CHI SQUARE TEST; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KRUSKAL WALLIS TEST; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PILOT STUDY; PREDICTION; PREDICTIVE VALUE; RANSON SCORE; RECEIVER OPERATING CHARACTERISTIC; SIMPLIFIED ACUTE PHYSIOLOGY SCORE;

ACUTE DISEASE; ADULT; AGED; B-CELL ACTIVATING FACTOR; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 84872327384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054297     Document Type: Article

References (18)

1. Pongratz G, Straub RH, Schölmerich J, Fleck M, Härle P, (2010) Serum BAFF strongly correlates with PsA activity in male patients only-is there a role for sex hormones? Clin Exp Rheumatol 28: 813-819.
2. Lied GA, Berstad A, (2011) Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol 73: 1-7.
3. Mackay F, Schneider P, (2009) Cracking the BAFF code. Nat Rev Immunol 9: 491-502.
4. Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, et al. (2007) Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 56: 3554-3563.
5. Fabris M, Visentini D, De R, V, Picierno A, Maieron R, et al. (2007) Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand J Gastroenterol 42: 1434-1439.
6. Davidson A, (2010) Targeting BAFF in autoimmunity. Curr Opin Immunol 22: 732-739.
7. Calero I, Sanz I, (2010) Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med 10: 416-424.
8. Lai Kwan LQ, King Hung KO, Zheng BJ, Lu L, (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 105: 14993-14998.
9. Wilson C, Heath DI, Imrie CW, (1990) Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 77: 1260-1264.
10. Ranson JH, Pasternack BS, (1977) Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 22: 79-91.
11. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, et al. (1974) Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 139: 69-81.
12. Werner J, Hartwig W, Uhl W, Muller C, Buchler MW, (2003) Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 3: 115-127.
13. Kylanpaa-Back ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppaniemi AK, et al. (2001) Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 29: 63-69.
14. Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, et al. (2001) Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 88: 222-227.
15. Muller CA, Uhl W, Printzen G, Gloor B, Bischofberger H, et al. (2000) Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 46: 233-238.
16. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, et al. (1999) Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 25: 195-210.
17. Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, et al. (2002) Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 89: 163-171.
18. Yamanishi H, Kumagi T, Yokota T, Azemoto N, Koizumi M, et al. (2011) Clinical significance of B cell-activating factor in autoimmune pancreatitis. Pancreas 40: 840-845.